Canadian hospitals face possible shortage of injectable pain medication

By

A possible shortage of injectable drugs, caused by reduced production at a Quebec plant, has many hospitals worried.

Sandoz says it is halting production lines because it failed inspections by the U.S. Food and Drug Agency.

Myrella Roy, the head of the Canadian Society of Hospital Pharmacists, said the news is worrisome.

“It’s potentially quite significant and quite disconcerning,” she told 680News.

Roy says various injectable drugs for pain, like morphine, will soon be in short supply.

Hospitals are going through their inventory and trying to minimize waste so the supply will last longer.

Roy says hospitals across Canada are also working with each other.

“Certainly within provinces and across provinces we’ll try and share supply as much as possible.”

She said they received little warning

Sandoze is now sending letters to hospitals, letting them know about what it is calling a critical national issue.

Top Stories

Top Stories

Most Watched Today